Next Article in Journal
Fast and Green Microwave-Assisted Conversion of Essential Oil Allylbenzenes into the Corresponding Aldehydes via Alkene Isomerization and Subsequent Potassium Permanganate Promoted Oxidative Alkene Group Cleavage
Next Article in Special Issue
Neuroprotection by Radical Avoidance: Search for Suitable Agents
Previous Article in Journal
Preparation and Characterization of Novel Gellan Gum Hydrogels Suitable for Modified Drug Release
Article Menu

Export Article

Open AccessArticle
Molecules 2009, 14(9), 3392-3410;

Identification of a Benzamide Derivative that Inhibits Stress-Induced Adrenal Corticosteroid Synthesis

Department of Biochemistry & Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA
The Research Institute of the McGill University Health Centre, Montreal, Quebec, H3G 1A4, Canada
Department of Medicine, McGill University, Montreal, Quebec, H3G 1A4, Canada
Samaritan Pharmaceuticals, Las Vegas, NV 89109, USA
Department of Pharmacology & Therapeutics, McGill University, Montreal, Quebec, H3G 1A4, Canada
Author to whom correspondence should be addressed.
Received: 27 July 2009 / Revised: 14 August 2009 / Accepted: 1 September 2009 / Published: 3 September 2009
(This article belongs to the Special Issue Neuroprotective Strategies)
Full-Text   |   PDF [278 KB, uploaded 18 June 2014]   |  


Elevated serum glucocorticoid levels contribute to the progression of many diseases, including depression, Alzheimer’s disease, hypertension, and acquired immunodeficiency syndrome. Here we show that the benzamide derivative N-[2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-1-(tert-butyl-1H-indol-3-yl-methyl)-2-oxo-ethyl]-4-nitrobenzamide (SP-10) inhibits dibutyryl cyclic AMP (dbcAMP)-induced corticosteroid synthesis in a dose-dependent manner in Y-1 adrenal cortical mouse tumor cells, without affecting basal steroid synthesis and reduced stress-induced corticosterone increases in rats without affecting the physiological levels of the steroid in blood. SP-10 did not affect cholesterol transport and metabolism by the mitochondria but was unexpectedly found to increase 3-hydroxy-3-methylglutaryl-coenzyme A, low density lipoprotein receptor, and scavenger receptor class B type I (SR-BI) expression. However, it also markedly reduced dbcAMP-induced NBD-cholesterol uptake, suggesting that this is a compensatory mechanism aimed at maintaining cholesterol levels. SP-10 also induced a redistribution of filamentous (F-) and monomeric (G-) actin, leading to decreased actin levels in the submembrane cytoskeleton suggesting that SP-10-induced changes in actin distribution might prevent the formation of microvilli–cellular structures required for SRBI-mediated cholesterol uptake in adrenal cells. View Full-Text
Keywords: steroid synthesis; cholesterol uptake; cortisol; adrenal; neuroprotection steroid synthesis; cholesterol uptake; cortisol; adrenal; neuroprotection

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Xu, J.; Lecanu, L.; Tan, M.; Greeson, J.; Papadopoulos, V. Identification of a Benzamide Derivative that Inhibits Stress-Induced Adrenal Corticosteroid Synthesis. Molecules 2009, 14, 3392-3410.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top